{"pdb_id": "6usx", "method": ["X-RAY DIFFRACTION"], "title": "Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer", "resolution": 2.27, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2019-10-28T00:00:00Z"}, "entity_id": "1", "entity_name": "GTPase KRas", "entity_type": "polypeptide(L)", "num_molecules": 2, "pdb_chain": "A", "struct_asym": "A"}
{"pdb_id": "6usx", "method": ["X-RAY DIFFRACTION"], "title": "Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer", "resolution": 2.27, "ncbi_taxon_id": 9606, "deposition_date": {"$date": "2019-10-28T00:00:00Z"}, "entity_id": "1", "entity_name": "GTPase KRas", "entity_type": "polypeptide(L)", "num_molecules": 2, "pdb_chain": "B", "struct_asym": "B"}
